- ICH GCP
- 미국 임상 시험 레지스트리
- Search trials
임상 시험 검색 : CC-220 1mg
총 2608 건
-
Janssen Research & Development, LLC완전한
-
University of BirminghamKing's College Hospital NHS Trust; University College London Hospitals; University of Nottingham 그리고 다른 협력자들완전한
-
New Discovery LLC모병
-
University of California, San DiegoNational Institute of Mental Health (NIMH)완전한
-
Boston UniversitySociety of Family Planning완전한
-
St Vincent's Hospital MelbourneMerck Sharp & Dohme LLC알려지지 않은
-
Hospitales Universitarios Virgen del RocíoBristol-Myers Squibb완전한
-
University of North Carolina, Chapel HillBristol-Myers Squibb; Gilead Sciences완전한
-
Institut CurieHoffmann-La Roche; Ministry of Health, France; Amgen; Pierre Fabre Laboratories모집하지 않고 적극적으로
-
National Cancer Institute (NCI)모병급성 성인 T세포 백혈병/림프종 | 성인 T세포 백혈병/림프종 | 만성 성인 T세포 백혈병/림프종 | HTLV-1 감염미국
-
National Cancer Institute (NCI)모집하지 않고 적극적으로앤아버 II기 미만성 대형 B세포 림프종 | 앤아버 III기 미만성 대형 B세포 림프종 | 앤아버 4기 미만성 거대 B세포 림프종미국
-
R.J. Reynolds Vapor CompanyCovance; R.J. Reynolds Tobacco Company; MAS (Materials Analytical Services), LLC완전한
-
Radboud University Medical CenterLondon School of Hygiene and Tropical Medicine; Kilimanjaro Christian Medical Centre, Tanzania완전한
-
University Hospital Inselspital, Berne모병
-
The Christie NHS Foundation TrustMerck Sharp & Dohme LLC; University of Manchester; Liverpool Clinical Trials Centre모병
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)완전한
-
National Institute of Mental Health (NIMH)완전한
-
Turku University HospitalHelsinki University Central Hospital; Oulu University Hospital; Kuopio University Hospital; Tampere University Hospital초대로 등록
-
M.D. Anderson Cancer Center모병
-
Merck Sharp & Dohme LLC완전한
-
Ache Laboratorios Farmaceuticos S.A.빼는
-
University of WashingtonBill and Melinda Gates Foundation종료됨
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)완전한
-
Merck Sharp & Dohme LLC완전한
-
University of Texas Southwestern Medical CenterThe Rogosin Institute완전한
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)모집하지 않고 적극적으로전이성 신장 세포 암종 | 3기 신세포암 AJCC v8 | IV기 신세포암 AJCC v8 | 전이성 신장 수질 암종 | SMARCB1 음성미국